Anixa Biosciences, Inc.
USD2.85
+0.06 (+2.15%)
CEO
Amit Kumar
IPO Date
1983-10-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.80
Prev. Close
$2.79
Day Low
$2.59
Day High
$2.85
52W Low
$2.32
52W High
$5.46
Market Cap
$0.10B
Volume
0.43M
| 21,000 |
| $2.50 |
| 29 Jan 2026 | Baskies Arnold M | director | P-Purchase | Acquired | 10,000 | $3.04 |
| 6 Jan 2026 | Titterton Lewis H jr | director | A-Award | Acquired | 25,000 | $3.18 |
| 6 Jan 2026 | KUMAR AMIT | director, officer: Chief Executive Officer | A-Award | Acquired | 350,000 | $3.18 |
| 6 Jan 2026 | Gottschalk Emily | director | A-Award | Acquired | 25,000 | $3.18 |
| 6 Jan 2026 | Catelani Michael | President, COO & CFO | A-Award | Acquired | 175,000 | $3.18 |
| 6 Jan 2026 | Baskies Arnold M | director | A-Award | Acquired | 25,000 | $3.18 |
| 16 Dec 2025 | Titterton Lewis H jr | director | M-Exempt | Acquired | 16,000 | $2.92 |
| 16 Dec 2025 | Titterton Lewis H jr | director | M-Exempt | Disposed | 16,000 | $2.92 |